Pressreleases

Three out of every four COVID-19 vaccine projects across the globe rely on SCHOTT vials

In 2019, SCHOTT announced a $1 billion investment in its pharmaceutical packaging business to expand capacity by more than 50%.

PBL’S Commitment to Erwinase® Supply and Quality

PBL is acutely aware of the importance of Erwinase® for children suffering from acute lymphoblastic leukaemia (ALL) and is committed to manufacturing the product such that it conforms to the highest specification meeting all quality standards required.

LTS Sponsors Microarray Patch Systems Webinar

Painless self-administration by the patient has the potential to be the lowest risk, lowest cost and most preferred option for drug delivery of injectable therapeutics. This Webinar will give you answers by introducing you to a superior dosage form.

Hosting Client Audits and Regulatory Inspections Remotely

In early 2020 Butterworth Laboratories Ltd (Butterworth) were eagerly anticipating a letter from the MHRA informing us of the intent

The Perfect Duo For Your Advanced Research and Quality Control

Thermal Analysis provides powerful analytical methods for research, development and quality control of active pharmaceutical ingredients (APIs), excipients and formulations.

New Edition of NSF’s Health Sciences Journal Now Live

This edition of the health sciences Journal is about hope and optimism, and how we must rethink our ways of working.

Securing your end-to-end supply chain

Supply chain safety, quality and reliability are key to all our Quats and Insulin Human customers. Here is how we can help you secure your supply chain, from sourcing raw materials to delivering your products as promised – even in a global crisis.

A Strong Signal in Turbulent Times: Vetter Achieves Carbon Dioxide-Neutral Levels

Contract Development and Manufacturing Organization further expands its commitment to climate protection.

LTS and LIVZON Enter License and Collaboration Agreement to Develop and Commercialize ASENAPINE TTS

LTS Lohmann Therapie-Systeme AG (LTS), a world-class pharmaceutical technology company headquartered in Andernach, Germany, and Livzon Pharmaceutical Group Inc. (Livzon),